hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Malaria campaigners hopeful on drugs pricing deal

Author: James Mackenzie, Reuters, Published on: 9 September 2008

Anti-malaria campaigners are confident that a deal can be reached with pharmaceuticals groups to cut the cost of new drugs needed to fight a disease estimated to kill more than 1 million people a year... Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria [said]..."Some firms were complaining that they had produced too much of these medicines. We're hoping an agreement will enable us to regulate the flow better so that everyone benefits."...Novartis and France's Sanofi are among the Western companies that make the drug but the sector has been shaken by the arrival of Chinese and Indian companies like Cipla and IPCA Laboratories.

Read the full post here

Related companies: Cipla IPCA Laboratories Novartis Sanofi